GlassScriptPhysician profile
Dennis Wayne Ashley
NPI 1821064361
$15,607.37
in general payments reported to CMS, 2019-2025
43 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 78% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $276 · 2021: $299 · 2022: $3,254 · 2023: $9,118 · 2024: $298 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,740 · Travel and Lodging: $3,305 · Food and Beverage: $2,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,740.01 |
| Travel and Lodging | $3,305.11 |
| Food and Beverage | $2,202.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,193.38 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Csl Behring | $3,124.19 | 2020-2023 | Kcentra |
| Penumbra, INC. | $1,427.60 | 2025 | Smart Coil, Ruby Coil |
| Medical Device Business Services, INC. | $900.25 | 2022 | |
| Depuy Synthes Sales INC. | $765.94 | 2020-2025 | Matrixrib |
| Aroa Biosurgery Incorporated | $761.78 | 2022-2025 | |
| Allergan, INC. | $312.79 | 2019-2022 | |
| Polynovo North America LLC | $288.47 | 2023-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $191.07 | 2019-2022 | |
| Stryker Corporation | $140.39 | 2022 | |
| Acell, INC. | $136.59 | 2019-2020 | |
| Polarityte, INC. | $122.97 | 2019-2020 | |
| Kerecis Limited | $116.48 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $105.55 | 2019-2023 | Seprafilm, Floseal |
| Medline Industries LP | $94.88 | 2022-2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Z-Medica, LLC | $77.83 | 2019 | |
| Avita Medical Americas, LLC | $75.90 | 2025 | Recell, Cohealyx, Permeaderm |
| Hologic Sales and Service, LLC | $62.41 | 2025 | Coolseal Generator |
| Ethicon US, LLC | $61.54 | 2019-2023 | Surgiflo Hemostatic Matrix, Vistaseal, Enseal |
| Zimmer Biomet Holdings, INC. | $54.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $54.03 | 2023-2024 | Andexxa |
| Haemonetics Corporation | $47.07 | 2019-2023 | Teg5000 Hemostasis Analyzer |
| La Jolla Pharmaceutical Company | $42.17 | 2023 | Xerava |
| Btg International INC. | $40.96 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $38.69 | 2020-2021 | |
| Abbvie INC. | $36.16 | 2023 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants |
| Alexion Pharmaceuticals, INC. | $33.22 | 2022 | |
| Becton, Dickinson and Company | $27.42 | 2023 | Xenmatrix Ab Surgical Graft |
| Biom'Up Sa | $26.04 | 2019 | |
| Lifenet Health | $23.12 | 2024 | Theragenesis Wound Matrix |
| Trevena, INC. | $23.05 | 2022 | |
| Avanos Medical | $22.98 | 2021 | |
| Sanara Medtech INC. | $22.84 | 2025 | Biasurge |
| Chiesi USA, INC. | $21.31 | 2019 | |
| Boston Scientific Corporation | $20.84 | 2024 | Wavewriter Alpha Prime 16 |
| Atricure, INC. | $20.41 | 2022 | |
| Novo Nordisk INC | $18.66 | 2023 | Wegovy |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Shire North American Group INC | $17.01 | 2019 | |
| Smith+Nephew, INC. | $13.19 | 2019 | |
| Applied Medical Technology INC | $12.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,563.80 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Ashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.